Results 1 to 10 of about 731 (123)

NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS

open access: yesРациональная фармакотерапия в кардиологии, 2015
Aim. To evaluate antianginal and antiischemic efficiency of nebivolol in patients with stable angina pectoris.Material and methods. 100 patients with ischemic heart disease showing stable exertional angina pectoris and having no contraindications to beta-
Y. V. Gavrilov   +2 more
doaj   +1 more source

Use of beta-blockers for the treatment of cardiovascular diseases: focus on metoprolol

open access: yesМедицинский совет, 2015
The article tells about the mechanisms of action of beta-blockers. Pharmacokinetic, pharmacodynamic and interaction properties of metoprolol are discussed.
O. D. Ostroumova, V. M. Fomina
doaj   +1 more source

EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To study effects of carvedilol and metoprolol on vegetative regulation of heart and microcirculatory vessels in patients with arterial hypertension (HT) of 1-2 degrees and high body mass/obesity.Material and methods. Patients with HT of 1-2 degrees (
A. R. Kiselev   +7 more
doaj   +1 more source

The possibility of using echocardiography in small laboratory animals for acute pharmacological tests

open access: yesФармакокинетика и Фармакодинамика, 2018
Resume. The purpose of this investigation is to study the adequacy of the echocardiography method in small laboratory animals for performing acute pharmacological tests.
E. O. Ionova   +4 more
doaj   +1 more source

COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To evaluate antihypertensive and metabolic effects of the therapy based on carvedilol (C) in comparison with metoprolol (M) in hypertensive patients with overweight or obesity.Material and methods.
S. Y. Martsevich   +62 more
doaj   +1 more source

Вартість профілактики мігрені препаратами топірамату

open access: yesAnnals of Mechnikov's Institute, 2023
Вступ. Відповідно до даних Всесвітньої організації охорони здоров’я, мігрень є одним із 20 захворювань, які найбільше обмежують життєдіяльність людини. Лікарські засоби (ЛЗ) першої лінії вибору для превентивної терапії мігрені, які визнані ефективними на
Yarina Grinkiv
doaj   +1 more source

COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To compare two therapies based on carvedilol or metoprolol in hypertensive patients with overweight and obesity.Material and methods. 320 patients with arterial hypertension (1-2 degree) were involved in the study.
S. Y. Martsevich   +26 more
doaj   +1 more source

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER

open access: yesРациональная фармакотерапия в кардиологии, 2016
Results of large randomized clinical trails on beta-blockers therapy of myocardial infarction (MI) with ST segment elevation (COMMIT/CCS-2, CAPRICORN) are analyzed.
B. N. Garifullin   +2 more
doaj   +1 more source

COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION

open access: yesРациональная фармакотерапия в кардиологии, 2015
Aim. To study efficiency and safety of new drug of long acting metoprolol tartrate, “Egilok retard” (ER) in patients with mild to moderate arterial hypertension (AH) in comparison with the original drug of metoprolol succinat, “Betaloc ZOK” (BZ ...
J. V. Lukina   +6 more
doaj   +1 more source

Vyyavlenie epizodov prekhodyashchey ishemii miokarda u bol'nykh IBS v sochetanii s SD 2 tipa metodami stress-ekhokardiografii i nagruzochnoy perfuzionnoy stsintigrafii i vozmozhnosti farmakologicheskoy korrektsii trimetazidinom MV

open access: yesСахарный диабет, 2007
Цель. Оценка распространенности и выраженности эпизодов болевой и безболевой ишемии миокарда по результатам стресс-ЭхоКГ и нагрузочной ПСМ на фоне 14-недельной терапии триметазидином МВ у больных ИБС в сочетании с СД 2 типа. Материалы и методы.
N V Mikova   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy